NEXORA●
BG|EN
SearchPROLogin
WorldBulgariaPoliticsBusinessEconomyTechnologyAIScienceClimateSportsCultureMarketsCrypto
Наука••NEXORA Editorial•Ars Technica

Obesity drug leads to weight loss of up to 25% in trial

Obesity drug leads to weight loss of up to 25% in trial

Related stories

Seabirds racing home across the ocean can experience jet lag
Наука • преди 14 ч

Seabirds racing home across the ocean can experience jet lag

FDA Seeks to Withdraw a Drug’s Approval, but the Process Is Not Simple
Наука • преди 14 ч

FDA Seeks to Withdraw a Drug’s Approval, but the Process Is Not Simple

NASA Features ‘Night on a Spooky Planet’ as Astronomy Picture of the Day
Наука • преди 21 ч

NASA Features ‘Night on a Spooky Planet’ as Astronomy Picture of the Day

Summary

Participants in a trial lost up to 25% of their body weight while taking an obesity drug. The results describe it as the most powerful drug of its kind to date, although no further details about the trial are provided.

Details

An obesity treatment has led participants in a clinical trial to lose up to 25% of their body weight, according to the information provided.

The result is presented as the largest reported weight loss achieved with an obesity drug to date. The available information does not identify the drug, state the number of participants or specify the duration of the trial.

No details have been provided about the study conditions, comparisons with other treatments or adverse effects. As a result, the findings cannot be assessed in greater detail on the basis of the available data.

NEXORA AI — Why it matters

The reported result points to a potentially significant development in drug treatments for obesity.

NEXORA PRO

Unlock detailed analysis, key facts, context, story developments, source comparisons, a personalized feed and smart alerts.

Explore NEXORA PRO

Read the original publication at Ars Technica